Analysis of Pax2 target genes involved in metanephric kidney morphogenesis

Pax2参与后肾形态发生的靶基因分析

基本信息

项目摘要

The human genome contains all of the information to make thousands of specialized cells and tissues during embryonic development. Even though all cells contain the same genes, cellular differentiation requires the selective activation and suppression of genes during development. Failure to correctly regulate this process of gene selectivity results in cancer, developmental abnormalities, cellular degeneration, and many other disease states. Gene activation and suppression patterns during cellular differentiation are specified by epigenetic mechanisms that are heritable and subject to modifications. Eukaryotic chromatin consists of DMA wrapped around a histone octamer. Modification of the core histone tails by acetylation, phosphorylation, methylation or ubiquitination can dramatically alter the local chromatin structure and the potential for gene expression. Accumulated biochemical and genetic evidence indicates that methylation at specific lysine residues of histones H3 and H4 can determine whether a gene remains accessible to the transcription machinery or whether it is silenced into tightly packaged heterochromatin. Such epigentic modifications of histones could account for a heritable cellular memory during embryonic development and could greatly affect gene expression patterns in diseased and aging cells. The Pax2 gene encodes a DNA binding protein and is essential for specifying the kidney and urogenital tract early in development. Loss of Pax2 function results in complete renal agenesis. Yet, overexpression of Pax2 is associated with a variety or renal diseases, including cancer and polycystic kidney disease. Recently, we identified a protein that links Pax2 to a mammalian histone H3 lysine 4 methyltransferase complex. In order to understand how this complex regulates renal patterning and disease, we must identify genes that are directly regulated by Pax2 and determine the sites of Pax2/DNA interactions. This propsal will take a systematic approach to define Pax2 target genes and Pax2 binding sites within the mouse genome. We will demonstrate changes in epigenetic imprinting patterns at these binding sites in response to Pax2 activity. Using both embryonic tissues and cell culture models, we will test the significance of Pax2/DNA interactions and characterize the modifcations of histone methylation at these sites. These experiments will define how a developmental regulatory gene that specifies cell fate can alter chromatin structure in a heritable way.
人类基因组包含制造数千种特殊细胞和组织的所有信息 在胚胎发育过程中。尽管所有细胞都含有相同的基因,但细胞分化 需要在发育过程中选择性激活和抑制基因。未能正确监管 这种基因选择性过程会导致癌症、发育异常、细胞退化和 许多其他疾病状态。细胞分化过程中的基因激活和抑制模式是 由可遗传且可修改的表观遗传机制指定。真核染色质 由包裹着组蛋白八聚体的 DMA 组成。通过乙酰化修饰核心组蛋白尾部, 磷酸化、甲基化或泛素化可以显着改变局部染色质结构和 基因表达的潜力。积累的生化和遗传证据表明,甲基化 组蛋白 H3 和 H4 的特定赖氨酸残基可以确定基因是否仍可被 转录机制或是否被沉默成紧密包装的异染色质。这样的表观遗传 组蛋白的修饰可以解释胚胎发育过程中可遗传的细胞记忆 可以极大地影响患病和衰老细胞的基因表达模式。 Pax2 基因编码 DNA 结合蛋白,对于确定肾脏和泌尿生殖系统至关重要 道处于开发早期。 Pax2 功能丧失会导致肾完全发育不全。然而,过度表达 Pax2与多种肾脏疾病相关,包括癌症和多囊肾病。 最近,我们发现了一种将 Pax2 与哺乳动物组蛋白 H3 赖氨酸 4 甲基转移酶连接的蛋白质 复杂的。为了了解这种复合物如何调节肾脏模式和疾病,我们必须确定 受 Pax2 直接调控并决定 Pax2/DNA 相互作用位点的基因。这个提案 将采取系统方法来定义小鼠体内的 Pax2 靶基因和 Pax2 结合位点 基因组。我们将展示这些结合位点的表观遗传印记模式的变化作为响应 Pax2 活动。使用胚胎组织和细胞培养模型,我们将测试 Pax2/DNA 相互作用并表征这些位点的组蛋白甲基化修饰。这些 实验将确定指定细胞命运的发育调控基因如何改变染色质 以可遗传的方式进行结构。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kristopher Robert Schwab其他文献

Kristopher Robert Schwab的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kristopher Robert Schwab', 18)}}的其他基金

Analysis of Pax2 target genes involved in metanephric kidney morphogenesis
Pax2参与后肾形态发生的靶基因分析
  • 批准号:
    7504792
  • 财政年份:
    2007
  • 资助金额:
    $ 5.13万
  • 项目类别:
Analysis of Pax2 target genes involved in metanephric kidney morphogenesis
Pax2参与后肾形态发生的靶基因分析
  • 批准号:
    7329262
  • 财政年份:
    2007
  • 资助金额:
    $ 5.13万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 5.13万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了